http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100400639-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46 |
| filingDate | 1996-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100400639-B1 |
| titleOfInvention | Heterocyclic amide compounds and their medicinal uses |
| abstract | A heterocyclic amide compound of the formula (I), a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and a pharmaceutical use thereof:n n n Formula In n n n n n n n Wherein each symbol is as defined in the specification.n n n The heterocyclic amide compound of the present invention and its pharmacologically acceptable salt thereof have an excellent inhibitory activity against the chimeric group in mammals including humans and can be administered orally or parenterally. Thus, they are useful as chimeric inhibitors and may be effective in the prevention and treatment of various diseases caused by chymase, such as diseases caused by angiotensin II. |
| priorityDate | 1995-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 502.